PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results

* Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025 * Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025 * Second quarter same-store sales were up 3.8%, and same-store prescription sales were up 5.2%, both compared to the second quarter of 2025 SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.

“Our second quarter reflected continued organic growth, disciplined integration, and active execution of acquisitions,” said Alan Simpson, Executive Chair of PharmaCorp. “With the closing of nine pharmacy acquisitions in July, together with the completion of the pharmacy acquisition in Western Canada on August 17, we are building momentum in our strategy to acquire, integrate and operate high-quality community pharmacies across Canada.”